EcoR1 Capital, LLC - Dec 31, 2024 SCHEDULE 13G/A Report for Eton Pharmaceuticals, Inc. Common Stock (ETON)

Filing Manager
EcoR1 Capital, LLC
Reporting Manager
EcoR1 Capital, LLC
Security
Eton Pharmaceuticals, Inc. Common Stock
Symbol
ETON
Shares outstanding
25.7M shares
Disclosed Ownership
1.98M shares
Ownership
7.7%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 01:04 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
EcoR1 Capital, LLC 7.7% 1.98M 0 1.98M /s/ Oleg Nodelman Manager
Oleg Nodelman 7.7% 1.98M 0 1.98M /s/ Oleg Nodelman Reporting person
EcoR1 Capital Fund Qualified, L.P. 7.2% 1.86M 0 1.86M /s/ Oleg Nodelman Manager of the General Partner, EcoR1 Capital, LLC